Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients

Shinta Mizuno, Masatoshi Wakui, Yujiro Machida, Naoki Hosoe, Tadakazu Hisamatsu, Takashi Ishida, Kaori Kameyama, Makoto Naganuma, Takanori Kanai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rationale: Mesenteric panniculitis (MP) is a rare disease with abdominal and systemic symptoms and is characterized by nonspecific inflammation, fat necrosis, and fibrosis in mesenteric fat. Active inflammatory responses may increase levels of prostaglandin E-major urinary metabolite (PGE-MUM), which was reported to reflect the disease activity of ulcerative colitis and chronic fibrosing interstitial pneumonia. We recently experienced a case with elevated PGE-MUM at the time of diagnosis of MP and we investigated the potential of PGE-MUM as a biomarker. Patient concern: In this report we described 2 active mesenteric panniculitis patients with high PGE-MUM levels. Diagnoses: Mesenteric panniculitis Interventions: Both MP patients were measured the levels of PGE-MUM. Outcomes: Both MP patients exhibited high levels of PGE-MUM before treatment. In one, the levels were sensitively correlated with clinical symptoms and serological markers on steroids. Lessons: The study observations suggest the potential of PGE-MUM to reflect the disease activity of MP. To verify its use, more findings based on clinical studies should be accumulated.

Original languageEnglish
Article numbere9237
JournalMedicine (United States)
Volume96
Issue number51
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Peritoneal Panniculitis
Prostaglandins E
Fat Necrosis
Interstitial Lung Diseases
Rare Diseases
Ulcerative Colitis
Fibrosis
Biomarkers
Fats
Steroids
Inflammation

Keywords

  • biomarker
  • mesenteric panniculitis
  • prostaglandin E-major urinary metabolite

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients. / Mizuno, Shinta; Wakui, Masatoshi; Machida, Yujiro; Hosoe, Naoki; Hisamatsu, Tadakazu; Ishida, Takashi; Kameyama, Kaori; Naganuma, Makoto; Kanai, Takanori.

In: Medicine (United States), Vol. 96, No. 51, e9237, 01.12.2017.

Research output: Contribution to journalArticle

@article{101d903460304f6eb81ea73edcb03cbb,
title = "Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients",
abstract = "Rationale: Mesenteric panniculitis (MP) is a rare disease with abdominal and systemic symptoms and is characterized by nonspecific inflammation, fat necrosis, and fibrosis in mesenteric fat. Active inflammatory responses may increase levels of prostaglandin E-major urinary metabolite (PGE-MUM), which was reported to reflect the disease activity of ulcerative colitis and chronic fibrosing interstitial pneumonia. We recently experienced a case with elevated PGE-MUM at the time of diagnosis of MP and we investigated the potential of PGE-MUM as a biomarker. Patient concern: In this report we described 2 active mesenteric panniculitis patients with high PGE-MUM levels. Diagnoses: Mesenteric panniculitis Interventions: Both MP patients were measured the levels of PGE-MUM. Outcomes: Both MP patients exhibited high levels of PGE-MUM before treatment. In one, the levels were sensitively correlated with clinical symptoms and serological markers on steroids. Lessons: The study observations suggest the potential of PGE-MUM to reflect the disease activity of MP. To verify its use, more findings based on clinical studies should be accumulated.",
keywords = "biomarker, mesenteric panniculitis, prostaglandin E-major urinary metabolite",
author = "Shinta Mizuno and Masatoshi Wakui and Yujiro Machida and Naoki Hosoe and Tadakazu Hisamatsu and Takashi Ishida and Kaori Kameyama and Makoto Naganuma and Takanori Kanai",
year = "2017",
month = "12",
day = "1",
doi = "10.1097/MD.0000000000009237",
language = "English",
volume = "96",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "51",

}

TY - JOUR

T1 - Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients

AU - Mizuno, Shinta

AU - Wakui, Masatoshi

AU - Machida, Yujiro

AU - Hosoe, Naoki

AU - Hisamatsu, Tadakazu

AU - Ishida, Takashi

AU - Kameyama, Kaori

AU - Naganuma, Makoto

AU - Kanai, Takanori

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Rationale: Mesenteric panniculitis (MP) is a rare disease with abdominal and systemic symptoms and is characterized by nonspecific inflammation, fat necrosis, and fibrosis in mesenteric fat. Active inflammatory responses may increase levels of prostaglandin E-major urinary metabolite (PGE-MUM), which was reported to reflect the disease activity of ulcerative colitis and chronic fibrosing interstitial pneumonia. We recently experienced a case with elevated PGE-MUM at the time of diagnosis of MP and we investigated the potential of PGE-MUM as a biomarker. Patient concern: In this report we described 2 active mesenteric panniculitis patients with high PGE-MUM levels. Diagnoses: Mesenteric panniculitis Interventions: Both MP patients were measured the levels of PGE-MUM. Outcomes: Both MP patients exhibited high levels of PGE-MUM before treatment. In one, the levels were sensitively correlated with clinical symptoms and serological markers on steroids. Lessons: The study observations suggest the potential of PGE-MUM to reflect the disease activity of MP. To verify its use, more findings based on clinical studies should be accumulated.

AB - Rationale: Mesenteric panniculitis (MP) is a rare disease with abdominal and systemic symptoms and is characterized by nonspecific inflammation, fat necrosis, and fibrosis in mesenteric fat. Active inflammatory responses may increase levels of prostaglandin E-major urinary metabolite (PGE-MUM), which was reported to reflect the disease activity of ulcerative colitis and chronic fibrosing interstitial pneumonia. We recently experienced a case with elevated PGE-MUM at the time of diagnosis of MP and we investigated the potential of PGE-MUM as a biomarker. Patient concern: In this report we described 2 active mesenteric panniculitis patients with high PGE-MUM levels. Diagnoses: Mesenteric panniculitis Interventions: Both MP patients were measured the levels of PGE-MUM. Outcomes: Both MP patients exhibited high levels of PGE-MUM before treatment. In one, the levels were sensitively correlated with clinical symptoms and serological markers on steroids. Lessons: The study observations suggest the potential of PGE-MUM to reflect the disease activity of MP. To verify its use, more findings based on clinical studies should be accumulated.

KW - biomarker

KW - mesenteric panniculitis

KW - prostaglandin E-major urinary metabolite

UR - http://www.scopus.com/inward/record.url?scp=85039760611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039760611&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000009237

DO - 10.1097/MD.0000000000009237

M3 - Article

C2 - 29390478

AN - SCOPUS:85039760611

VL - 96

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 51

M1 - e9237

ER -